ARCHIVES

Bush Limits Drug Company Efforts To Block Generics

This article is from The Cancer Letter archive.

Vol. 28 No. 39 | October 25, 2002

Download PDF Visit The Full Archive

Related Articles

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

November 6, 2009

European regulators plan more rigorous rules for accelerated approval in cancer.

November 11, 2005

Varmus Discusses Grant Policy, Changes in Congress and Ebola

December 12, 2014

SWOG Releases RFA For Use Of Biorepository

November 12, 2010

NCI Advisory Group, Other Cancer Meetings

February 24, 1989

In Brief: Holland Retires As Center Director, Replaced By NCI’s Aaronson; Lab Chiefs Leaving NCI

September 24, 1993